Literature DB >> 23465872

Spontaneous hemothorax following thrombolytic and anticoagulant therapy for massive pulmonary embolism.

Chung-Cheng Wang1, Chip-Jin Ng, Chen-Ken Seak, Chen-June Seak.   

Abstract

Massive spontaneous hemothorax following combined thrombolytic and anticoagulant therapy for pulmonary embolism(PE) is a rare event that is little documented in the literature. Here, we describe a rare case of spontaneous hemothorax in a 23-year-old woman with underlying systemic lupus erythematosus following combined administration of tissue plasminogen activator and low-molecular-weight heparin for massive PE. This report of our successful treatment of this case by video-assisted thoracoscopic thoracotomy demonstrates that although the occurrence is rare, massive hemothorax following anticoagulant and/or thrombolytic therapy for PE should be suspected if patients experience chest pain, dyspnea, or signs of anemia, and follow-up physical examination and hemogram should be performed to facilitate diagnosis of this life-threatening complication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23465872     DOI: 10.1016/j.ajem.2013.01.037

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  1 in total

1.  Spontaneous hemothorax resulting from tissue plasminogen activator in a patient with ischemic stroke and unrecognized recent myocardial infarction.

Authors:  Daniel A Kelmenson; Jonathan S Kurche; Mark Geraci
Journal:  Ann Am Thorac Soc       Date:  2015-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.